Neolignans as emerging anticancer leads: Isolation, chemical diversity, structure-activity relationships.
Many therapeutic plants contain structurally varied natural phenylpropanoid dimers called neolignans, which are biosynthesized via non-8,8' oxidative coupling routes. They are attractive candidates for anticancer drug development because of their chemical diversity, multitarget pharmacological activity, and ability to...